201 related articles for article (PubMed ID: 10924619)
1. GB virus type C/HGV markers in HCV RNA-positive French blood donors: correlation with HCV genotypes and risk factors.
Bouchardeau F; Laperche S; Pillonel J; Elghouzzi MH; Maisonneuve P; Tirtaine C; Boiret E; Razer A; Girault A; Beaulieu MJ; Couroucé AM
Transfusion; 2000 Jul; 40(7):875-8. PubMed ID: 10924619
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of hepatitis B, hepatitis C, and GB virus C/hepatitis G virus infections in liver disease patients and inhabitants in Ho Chi Minh, Vietnam.
Kakumu S; Sato K; Morishita T; Trinh KA; Nguyen HB; Banh VD; Do HC; Nguyen HP; Nguyen VT; Le TT; Yamamoto N; Nakao H; Isomura S
J Med Virol; 1998 Apr; 54(4):243-8. PubMed ID: 9557289
[TBL] [Abstract][Full Text] [Related]
3. Interspousal transmission of GB virus-C/hepatitis G virus: a comparison with hepatitis C virus.
Kao JH; Liu CJ; Chen PJ; Chen W; Hsiang SC; Lai MY; Chen DS
J Med Virol; 1997 Dec; 53(4):348-53. PubMed ID: 9407382
[TBL] [Abstract][Full Text] [Related]
4. Correlation of interferon treatment response with GBV-C/HGV genomic RNA and anti-envelope 2 protein antibody.
Tanaka T; Hess G; Schlueter V; Zdunek D; Tanaka S; Kohara M
J Med Virol; 1999 Apr; 57(4):370-5. PubMed ID: 10089049
[TBL] [Abstract][Full Text] [Related]
5. Follow-up of four HIV-infected individuals after administration of hepatitis C virus and GBV-C/hepatitis G virus contaminated intravenous immunoglobulin: evidence for HCV but not for GBV-C/HGV transmission.
Berger A; Doerr HW; Scharrer I; Weber B
J Med Virol; 1997 Sep; 53(1):25-30. PubMed ID: 9298728
[TBL] [Abstract][Full Text] [Related]
6. GBV-C/HGV infection in hepatitis C virus-infected deferred Swedish blood donors.
Shev S; Björkman P; Norkrans G; Foberg U; Frydén A; Lindh G; Lindholm A; Weiland O; Widell A
J Med Virol; 1998 Feb; 54(2):75-9. PubMed ID: 9496362
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and genotypes of GB virus C/hepatitis G virus (GBV-C/HGV) and hepatitis C virus among patients infected with human immunodeficiency virus: evidence of GBV-C/HGV sexual transmission.
Ibáñez A; Giménez-Barcons M; Tajahuerce A; Tural C; Sirera G; Clotet B; Sánchez-Tapias JM; Rodés J; Martínez MA; Saiz JC
J Med Virol; 1998 Aug; 55(4):293-9. PubMed ID: 9661838
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis G virus (GBV-C) infection among Brazilian patients with chronic liver disease and blood donors.
Lampe E; de Oliveira JM; Pereira JL; Saback FL; Yoshida CF; Niel C
Clin Diagn Virol; 1998 Jan; 9(1):1-7. PubMed ID: 9562852
[TBL] [Abstract][Full Text] [Related]
9. Comparison of characteristics between patients with GB virus C/hepatitis G virus (GBV-C/HGV) RNA and those with GBV-C/HGV E2-antibody in patients with hemophilia.
Toyoda H; Takahashi I; Fukuda Y; Hayakawa T; Takamatsu J
J Med Virol; 2000 Jan; 60(1):34-8. PubMed ID: 10568760
[TBL] [Abstract][Full Text] [Related]
10. High rate of GB virus type C/HGV transmission from mother to infant: possible implications for the prevalence of infection in blood donors.
Lefrère JJ; Sender A; Mercier B; Mariotti M; Pernot F; Soulié JC; Malvoisin A; Berry M; Gabai A; Lattes F; Galiay JC; Pawlak C; de Lachaux V; Chauveau V; Hreiche G; Larsen M; Férec C; Parnet-Mathieu F; Roudot-Thoraval F; Brossard Y
Transfusion; 2000 May; 40(5):602-7. PubMed ID: 10827267
[TBL] [Abstract][Full Text] [Related]
11. Molecular investigation of GB virus C RNA in hemodialysis and thalassemics patients from Brazil.
Watanabe MA; Milanezi CM; Silva WA; de Lucena Angulo I; Santis G; Kashima S; da Costa JA; Neto MM; Covas DT
Ren Fail; 2003 Jan; 25(1):67-75. PubMed ID: 12617334
[TBL] [Abstract][Full Text] [Related]
12. Seroprevalence of GB virus C/hepatitis G virus-RNA and anti-envelope antibody in high-risk populations in Taiwan.
Hwang SJ; Chu CW; Lu RH; Lan KH; Wu JC; Wang YJ; Chang FY; Lee SD
J Gastroenterol Hepatol; 2000 Oct; 15(10):1171-5. PubMed ID: 11106098
[TBL] [Abstract][Full Text] [Related]
13. Infection with hepatitis G virus and its strain variant, the GB agent (GBV-C), among blood donors in Japan.
Yoshikawa A; Fukuda S; Itoh K; Kosaki N; Suzuki T; Hirakawa K; Nakao H; Inoue T; Fukuda M; Okamoto H
Transfusion; 1997 Jun; 37(6):657-63. PubMed ID: 9191829
[TBL] [Abstract][Full Text] [Related]
14. A case-control study of transmission routes for GB virus C/hepatitis G virus in Swedish blood donors lacking markers for hepatitis C virus infection.
Björkman P; Nauclér A; Winqvist N; Mushahwar I; Widell A
Vox Sang; 2001 Oct; 81(3):148-53. PubMed ID: 11703856
[TBL] [Abstract][Full Text] [Related]
15. High prevalence of GB virus C/hepatitis G virus infection among homosexual men infected with human immunodeficiency virus type 1: evidence for sexual transmission.
Nerurkar VR; Chua PK; Hoffmann PR; Dashwood WM; Shikuma CM; Yanagihara R
J Med Virol; 1998 Oct; 56(2):123-7. PubMed ID: 9746067
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of GB virus C/hepatitis G virus ribonucleic acid and anti-hepatitis G virus-E2 antibodies among Japanese children with histories of transfusions or with liver diseases.
Goto K; Sugiyama K; Li R; Miyake Y; Ando T; Mizutani F; Terabe K; Mizuno K; Wada Y
Pediatr Res; 1999 Jan; 45(1):128-32. PubMed ID: 9890620
[TBL] [Abstract][Full Text] [Related]
17. HGV/GBV-C in liver tissue and in sera from patients with chronic hepatitis C.
Fabris P; Biasin MR; Infantolino D; Romanó L; Benedetti P; Tositti G; Pellizzer GP; Zanetti AR; Stecca C; Marchelle G; de Lalla F
Infection; 1998; 26(5):283-7. PubMed ID: 9795785
[TBL] [Abstract][Full Text] [Related]
18. [GB virus-C/hepatitis G virus--discovery, epidemiology, diagnosis and clinical relevance].
Sarrazin C; Roth WK; Zeuzem S
Z Gastroenterol; 1998 Nov; 36(11):997-1008. PubMed ID: 9880826
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus and GB virus C/hepatitis G virus viremia in Swedish blood donors with different alanine aminotransferase levels.
Björkman P; Sundström G; Widell A
Transfusion; 1998 Apr; 38(4):378-84. PubMed ID: 9595021
[TBL] [Abstract][Full Text] [Related]
20. Comparison of GB virus C, HIV, and HCV infection markers in hemophiliacs exposed to non-inactivated or inactivated factor concentrates.
Kupfer B; Ruf T; Matz B; Nattermann J; Spengler U; Rockstroh JK; Brackmann HH; Blümel J; Tacke M; Kaiser R
J Clin Virol; 2005 Sep; 34(1):42-7. PubMed ID: 16087123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
